Show simple item record

NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis

dc.contributor.authorBanerjee, Poulomi
dc.contributor.authorElliott, Elizabeth
dc.contributor.authorRifai, Olivia M
dc.contributor.authorO'shaughnessy, Judi
dc.contributor.authorMcDade, Karina
dc.contributor.authorAbrahams, Sharon
dc.contributor.authorChandran, Siddharthan
dc.contributor.authorSmith, Colin
dc.contributor.authorGregory, Jenna
dc.date.accessioned2022-07-08T11:30:00Z
dc.date.available2022-07-08T11:30:00Z
dc.date.issued2022-03
dc.identifier217891336
dc.identifier6ce6bcd4-3e48-471b-aa04-14f2d1f97f99
dc.identifier85122315747
dc.identifier.citationBanerjee , P , Elliott , E , Rifai , O M , O'shaughnessy , J , McDade , K , Abrahams , S , Chandran , S , Smith , C & Gregory , J 2022 , ' NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis ' , The Journal of pathology , vol. 256 , pp. 262-268 . https://doi.org/10.1002/path.5846en
dc.identifier.issn0022-3417
dc.identifier.otherORCID: /0000-0003-3337-4079/work/112143940
dc.identifier.urihttps://hdl.handle.net/2164/18827
dc.descriptionFunding Pathological Society of Great Britain and Ireland. Grant Number: Jean Shanks Foundation Clinical Lecturer Support G OR is funded by a Wellcome Trust PhD fellowship (108890/Z/15/Z). JMG is funded by a starter grant for clinical lecturers from the AMS (210JMG 3102 R45620) and a Clinical Lecturer Support Grant from The Pathological Society/Jean Shanks Foundation, and brain bank funding from the MRC (MR/L016400/1). EE is funded by a PhD fellowship from the CSO and MND Scotland: 217ARF R45951.en
dc.format.extent7
dc.format.extent18950650
dc.language.isoeng
dc.relation.ispartofThe Journal of pathologyen
dc.subjectcognitionen
dc.subjectamyotrophic lateral sclerosis;en
dc.subjectNLRP3 inflammasomeen
dc.subjectinterleukin 6en
dc.subjectnterleukin 10en
dc.subjectSIRT2en
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subjectWellcome Trusten
dc.subject108890/Z/15/Zen
dc.subjectOtheren
dc.subject210JMG 3102 R45620en
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/L016400/1en
dc.subjectChief Scientist Office (CSO)en
dc.subject217ARF R45951en
dc.subjectSupplementary Dataen
dc.subject.lccRC0321en
dc.titleNLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Neuroscienceen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1002/path.5846
dc.identifier.urlhttp://dx.doi.org/10.1002/path.5846en
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85122315747&partnerID=8YFLogxKen
dc.identifier.vol256en


Files in this item

Thumbnail
Name:
Banerjee_etal_JoP_NLRP3_inflam ...
Size:
18.07Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record